You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tuberculin Purified Protein Derivative

Showing 1 - 25 of 9,425
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy, Latent Tuberculosis Infection (LTBI) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Tuberculin

Recruiting
  • Healthy
  • Latent Tuberculosis Infection (LTBI)
  • Tuberculin Purified Protein Derivative
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 22, 2022

Latent Tuberculosis Infection Trial (Recombinant Mycobacterium Tuberculosis Fusion Protein, Purified Protein Derivative of

Not yet recruiting
  • Latent Tuberculosis Infection
  • Recombinant Mycobacterium Tuberculosis Fusion Protein
  • Purified Protein Derivative of Tuberculin
  • (no location specified)
Jun 8, 2023

Delayed Type Hypersensitivity Trial in Montreal (Prednisone, Placebo)

Completed
  • Delayed Type Hypersensitivity
  • Montreal, Quebec, Canada
    Innovaderm Research Inc.
Jul 16, 2020

Common Wart Trial (Tuberculin purified protein derivative)

Unknown status
  • Common Wart
  • Tuberculin purified protein derivative
  • (no location specified)
Feb 26, 2020

Tuberculosis Trial in Shanghai (Placebo, Low dose adjuvant, High dose adjuvant)

Completed
  • Tuberculosis
  • Placebo
  • +4 more
  • Shanghai, Shanghai, China
    Shanghai Public Health clinical Center
Mar 9, 2022

Tuberculosis Trial in Wuhan (Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02), Low-dose adjuvant for

Completed
  • Tuberculosis
  • Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
  • +2 more
  • Wuhan, Hubei, China
    Wuhan Infectious Disease Hospital
Sep 2, 2022

Methods in People Living With Retroviral Infection in Liberia

Active, not recruiting
  • Tuberculosis
  • HIV
    • Bethesda, Maryland
    • +4 more
    Jan 14, 2023

    Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts Trial in Zagazig (Intralesional antigen

    Completed
    • Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts
    • Intralesional antigen immunotherapy
    • Zagazig, Sharkia, Egypt
      Zagazig university
    Feb 14, 2022

    Latent Tuberculosis Infection Trial (Recombinant Mycobacterium tuberculosis fusion protein for injection, TB-PPD was injected)

    Not yet recruiting
    • Latent Tuberculosis Infection
    • Recombinant Mycobacterium tuberculosis fusion protein for injection
    • TB-PPD was injected
    • (no location specified)
    Feb 16, 2023

    Cutaneous Warts Trial (Hepatitis B Virus Vaccine(HBV))

    Not yet recruiting
    • Cutaneous Warts
    • Hepatitis B Virus Vaccine(HBV)
    • (no location specified)
    Jun 13, 2023

    Atopic Dermatitis Trial in London (Skin biopsy, Skin suction blister, Mantoux test)

    Withdrawn
    • Atopic Dermatitis
    • Skin biopsy
    • +2 more
    • London, United Kingdom
      Royal Free London NHS Foundation Trust
    Apr 27, 2021

    Warts Trial (topical methotrexate hydrogel 1% coupled with microneedling., Liquid nitrogen)

    Not yet recruiting
    • Warts
    • topical methotrexate hydrogel 1% coupled with microneedling.
    • Liquid nitrogen
    • (no location specified)
    Mar 18, 2022

    Tuberculosis Trial (Bacillus Calmette - Guerin, of Bacillus Calmette - Guerin)

    Completed
    • Tuberculosis
    • Bacillus Calmette - Guerin
    • placebo of Bacillus Calmette - Guerin
    • (no location specified)
    Sep 29, 2020

    Self-Assessment Tuberculin Skin Test

    Completed
    • Tuberculin Skin Test
    • The participants do not receive any intervention for this study
    • Bangkok, Thailand
    • +1 more
    Jul 14, 2020

    CTCL, Mycosis Fungoides, Sezary Syndrome Trial in New York (Ritlecitinib)

    Recruiting
    • CTCL
    • +2 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    May 18, 2023

    Latent Tuberculosis, Persistent Infection, Mycobacterium Tuberculosis Trial in Malmö

    Recruiting
    • Latent Tuberculosis
    • +2 more
      • Malmö, Skåne, Sweden
        Skåne University Hospital
      Nov 10, 2022

      HIV, Tuberculosis Trial in United States (Isoniazid, Pyrazinamide, Pyridoxine HCl)

      Completed
      • HIV Infections
      • Tuberculosis
      • San Francisco, California
      • +24 more
      Oct 26, 2021

      Allergic Rhinitis, Asthma, Latent Tuberculosis Trial in Paddington (Poly ICLC, Poly I:C, R848)

      Completed
      Has Results
      • Allergic Rhinitis
      • +2 more
      • Poly ICLC
      • +5 more
      • Paddington, London, United Kingdom
        Imperial Clinical Respiratory Research Unit (ICRRU), St Mary's H
      Nov 3, 2021

      HIV, Tuberculosis Trial in United States (Isoniazid, Pyridoxine HCl)

      Completed
      • HIV Infections
      • Tuberculosis
      • Los Angeles, California
      • +13 more
      Oct 27, 2021

      HIV, Tuberculosis Trial in Puerto Rico, United States (Isoniazid, Pyrazinamide, Pyridoxine HCl)

      Completed
      • HIV Infections
      • Tuberculosis
      • Birmingham, Alabama
      • +75 more
      Oct 26, 2021

      Epidemic Meningitis Trial (MCV4)

      Not yet recruiting
      • Epidemic Meningitis
      • MCV4
      • (no location specified)
      Jul 5, 2023

      Filarial Infection on Immune Responses in Latent Tuberculosis

      Completed
      • Mycobacterium Infections
      • +3 more
        • Bethesda, Maryland
        • +1 more
        Apr 19, 2021

        Psoriasis Trial in Bonn, Berlin, London (GSK2831781, Placebo)

        Completed
        Has Results
        • Psoriasis
        • GSK2831781
        • Placebo
        • Bonn, Nordrhein-Westfalen, Germany
        • +2 more
        Feb 26, 2021

        Transitional Cell Carcinoma Trial in New York (TICE®-strain BCG, NY-ESO-1 protein, sargramostim)

        Completed
        Has Results
        • Transitional Cell Carcinoma
        • TICE®-strain BCG
        • +2 more
        • New York, New York
          Memorial Sloan-Kettering Cancer Center
        Oct 3, 2022

        Pulmonary Tuberculosis Trial in Chennai (Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol)

        Completed
        • Pulmonary Tuberculosis
        • Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol
        • Chennai, Tamilnadu, India
          Tuberculosis Research Centre
        Apr 13, 2021